Abstract
Objective To investigate the effect of thoracoscopic anatomical segmentectomy on stage IA non-small cell lung cancer (NSCLC) and its effect on pulmonary function. Methods 64 patients with stage IA non-small cell lung cancer admitted to our hospital from August 2016 to September 2018 were divided into observation group and control group, 32 cases in each group. The observation group was treated with thoracoscopic anatomical segmentectomy, while the control group was treated with lobectomy. The therapeutic effects of the two groups were compared. Results The bleeding volume, drainage volume, drainage time, and hospitalization time in the observation group were less than those in the control group (P 0.05). On the 1st and 2nd days after operation, CRP levels in the two groups were significantly higher than those before operation, but those in the observation group were significantly lower than those in the control group (P 0.05). Conclusion Thoracoscopic anatomical segmentectomy for stage IA non-small cell lung cancer is minimally invasive, which can shorten the recovery time of patients and protect lung function. Key words: Thoracoscopy; Anatomical segmentectomy; Non-small cell lung cancer; Lung function
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
